Sequoia Capital
http://www.sequoiacap.com/Sequoia Capital is a multi-stage venture capital firm that invests in high-quality fast growing companies. The firm’s four staple investment categories are services, software, systems, and components. Sequoia was the first capital investor and business partner in companies that makeup 10% of the NASDAQ’s total value. Successful investments by the firm have included YouTube, Oracle (ORCL), and Electronic Arts (ERTS).
View Older Stories View More Recent Stories
-
Form D Sequoia Capital Growth
-
DraftKings and Flutter stocks fall after Kalshi raises $300M
-
PingCAP Launches TiDB X and New AI Capabilities at SCaiLE Summit 2025
-
Chainguard Research Shows Engineers Struggle With Burnout, Maintenance, and Tool Sprawl Despite AI Gains
-
Versa Named Industry Leader and Outperformer in GigaOm® SD-WAN Report for Second Year
-
Grafana Labs Revolutionizes AI-Powered Observability with GA of Grafana Assistant and Introduces Assistant Investigations
-
Grafana Labs Redefines Observability Economics with Adaptive Telemetry, Bring Your Own Cloud, and FedRAMP-Authorized Cloud
-
Grafana Labs Unveils Breakthroughs in Full-Stack and Database Observability
-
Riviera Partners Welcomes Josh Narva as Partner to Lead Talent Advisory Capabilities
-
Pendulum Therapeutics Appoints Former Starbucks CEO Laxman Narasimhan to Board of Directors
-
Productboard Unveils Productboard Spark: Specialized AI to Supercharge Product Managers
-
Freed Unveils EHR Push: One-Click AI Note Transfer Into Any Web-Based EHR
-
Faraday Future invests $41 million in Qualigen Therapeutics
-
Univest Securities, LLC Announces Closing of $41 Million Strategic Investment in Client Qualigen Therapeutics (NASDAQ: QLGN) from Client Faraday Future (NASDAQ: FFAI)
-
Grafana Labs Surpasses $400M ARR and 7,000 Customers, Gains New Investors to Accelerate Global Expansion
-
Qualigen closes $41 million PIPE led by Faraday Future for crypto pivot
-
Qualigen Therapeutics Announces Successful Closing of $41 Million PIPE Financing Led by Faraday Future, Accelerating New Business Transformation into Crypto
-
Faraday Future completes $41 million investment in Qualigen Therapeutics
-
Faraday Future Announces Closing of Strategic $41 Million Investment in Qualigen Therapeutics (NASDAQ: QLGN) to Accelerate its Dual-Flywheel & Dual-Bridge Eco Strategy
-
Faraday Future Announces Closing of Strategic $41 Million Investment in Qualigen Therapeutics (NASDAQ: QLGN) to Accelerate its Dual-Flywheel & Dual-Bridge Eco Strategy
-
Tula Technology Announces Development Agreements for Global and Regional Automotive Applications
-
Paid Raises $21 Million Seed to Build Infrastructure for the AI Agent Economy
-
Capitolis Named World's Best FX Solution for Client Service in 2025 Euromoney Foreign Exchange Awards
-
Ethos Technologies reveals 55% revenue surge as insurance IPOs fire up
-
Factory Unleashes the Droids, Raises $50 Million Series B from NEA, Sequoia Capital, NVIDIA, and J.P. Morgan
-
Prelude Security Announces Additional $16M Investment Led by Brightmind Partners, Along With Sequoia Capital and Insight Partners, To Build the Next Generation of Endpoint Security
-
Introducing Chainguard Libraries for JavaScript: Malware-Resistant Dependencies Built Entirely from Source
-
Chainguard Announces Chainguard Containers Availability in AWS Marketplace for Use in the AWS GovCloud (US) Region
-
Grow Therapy Raises the Privacy Bar in Mental Health
-
Founders Fund and Sequoia Back Brazilian AI Startup Enter in $350M Valuation Bet on the World’s Toughest Legal Market
-
Anchore and Chainguard Partner to Deliver Next-Generation Supply Chain Security
-
Faraday Future invests $41 million in Qualigen Therapeutics for crypto business
-
Faraday Future Announced a Total Strategic Investment of $41 million in Qualigen Therapeutics, Inc. (NASDAQ: QLGN) During its Annual 919 Event, for its Crypto Business Focusing on Three Growth Engines
-
Faraday Future Announces Strategic $41 Million Investment in Qualigen Therapeutics, Inc. (NASDAQ: QLGN) for Crypto Business Through PIPE Transaction
-
Faraday Future Announces Strategic $41 Million Investment in Qualigen Therapeutics, Inc. (NASDAQ: QLGN) f for Crypto Business Through PIPE Transaction
-
Fitness tracking app Strava looks to hire banks for IPO
-
Leading Research Firm Names Versa Among Top SASE Providers
-
Oasis Security Launches First-Ever Non-Human Identity Management Certification
-
Domino Data Lab Achieves ISO 9001:2015 Certification, and SOC 2 Type II Compliance with Zero Findings
-
Capitolis Appoints Fintech and Capital Markets Executive Melanie Carucci as Global Head of Sales
-
SecurityScorecard Acquires HyperComply to Bring AI-Powered Automation to Supply Chain Risk Management
-
MarqVision Lands $48M Series B to Power Brand Control and Revenue Growth for Global Brands
-
Versa Announces New Integrations with CrowdStrike Falcon Platform
-
Hoxton Ventures Expands Team and U.S. Presence to Support Growing Portfolio
-
Domino Data Lab Named a Leader Three Years in a Row Across Two Dresner Advisory Reports on AI
-
Klarna valued at nearly $20 billion as shares jump in NYSE debut
-
Klarna raises $1.37 billion in US IPO, boosting fintech hopefuls
-
RobCo Launches in the US With New San Francisco HQ to Meet Soaring Automation Demand Amid Industry Reshoring Drive and Labor Shortage
-
ElevenLabs staff to sell shares at $6.6 billion valuation, Bloomberg News reports
-
Cellworks Unveils a Breakthrough in Predicting Chemo-Immunotherapy Benefit for Patients with Metastatic NSCLC

